Jeong-Joong Yoon

6PUBLICATIONS
27CO-AUTHORS
Medical infection agents (incl. prions)Medical devicesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 22, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models.

|Feb 08, 2024
Therapeutic mitigation of measles-like immune amnesia and exacerbated disease after prior respiratory virus infections in ferrets.

Robert M Cox, Josef D Wolf, Nicole A Lieberman

|Jun 24, 2022
Orally efficacious lead of the AVG inhibitor series targeting a dynamic interface in the respiratory syncytial virus polymerase.

Julien Sourimant, Carolin M Lieber, Jeong-Joong Yoon

|Dec 02, 2021
4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.

Julien Sourimant, Carolin M Lieber, Megha Aggarwal

|Jul 15, 2020
Orally efficacious broad-spectrum allosteric inhibitor of paramyxovirus polymerase.

Robert M Cox, Julien Sourimant, Mart Toots

|Oct 25, 2019
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia.

Mart Toots, Jeong-Joong Yoon, Robert M Cox

Pageof 1

Frequent Collaborators

6 joint publications

Richard K Plemper

5 joint publications

Zachary Sticher

3 joint publications

Josef D Wolf

3 joint publications

Alexander L Greninger